Respiratory chain deficiency slows down cell-cycle progression via reduced ROS generation and is associated with a reduction of p21CIP1/WAF1

Journal of Cellular Physiology

Volumn 209, Issue 1, 2006, Pages 103-112

  Schauen, Matthias ^a,c   Spitkovsky, Dimitry ^a   Schubert, Jens ^a   Fischer, Jürgen H ^a   Hayashi, Jun Ichi ^b   Wiesner, Rudolf J ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c Institute of Vegetative Physiology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CYCLIN D3; CYCLIN DEPENDENT KINASE 6; CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN DEPENDENT KINASE INHIBITOR 2C; ETHIDIUM BROMIDE; MITOCHONDRIAL DNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; PROTEIN P18; REACTIVE OXYGEN METABOLITE; UBIQUINONE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTRON TRANSPORT; FLOW CYTOMETRY; GROWTH REGULATION; HUMAN; HUMAN CELL; MITOCHONDRIAL RESPIRATION; PRIORITY JOURNAL; PROTEIN INTERACTION; RESPIRATORY CHAIN; WILD TYPE;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; CELL CYCLE; CELL CYCLE PROTEINS; CELL ENLARGEMENT; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; ETHIDIUM; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HELA CELLS; HEME; HUMANS; MITOCHONDRIAL DISEASES; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; URIDINE; URIDINE TRIPHOSPHATE;

EID: 33748283347     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20711     Document Type: Article

References (60)

1. Adlam VJ, Harrison JC, Porteous CM, James AM, Smith RA, Murphy MP, Sammut IA. 2005. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J 19:1088-1095.
2. Appleby RD, Porteous WK, Hughes G, James AM, Shannon D, Wei YH, Murphy MP. 1999. Quantitation and origin of the mitochondrial membrane potential in human cells lacking mitochondrial DNA. Eur J Biochem 262:108-116.
3. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
4. Burdon RH. 1994. Free radicals and cell proliferation. In: Rice-Evans CA, Burdon RH, editors. Free radical damage and its control. Amsterdam, Netherlands: Elsevier. pp. 155-185.
5. Cheng M, Olivier P, Diehl JA, Fero M, Roussel MF, Roberts JM, Sherr CJ. 1999. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J 18:1571-1583.
6. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA. 1995. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789.
7. Desjardins P, Frost E, Morais R. 1985. Ethidium bromide-induced loss of mitochondrial DNA from primary chicken embryo fibroblasts. Mol Cell Biol 5:1163-1169.
8. Dotto GP. 2000. p21(WAF1/Cip1): More than a break to the cell cycle? Biochim Biophys Acta 1471:M43-M56.
9. Finkel T. 2003. Oxidant signals and oxidative stress. Curr Opin Cell Biol 15:247-254.
10. Fischer JH. 1995. Specific detection of nucleotides, creatine phosphate, and their derivatives from tissue samples in a simple, isocratic, recycling, low-volume system. LC GC Int 8:254-259.
11. Gardner PR. 2002. Aconitase: Sensitive target and measure of superoxide. Superoxide Dismutase 349:9-23.
12. Gartel AL, Radhakrishnan SK. 2005. Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res 65:3980-3985.
13. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. 1993. The P21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
14. Hayashi J, Ohta S, Kikuchi A, Takemitsu M, Goto Y, Nonaka I. 1991. Introduction of disease-related mitochondrial DNA deletions into HeLa cells lacking mitochondrial DNA results in mitochondrial dysfunction. Proc Natl Acad Sci USA 88:10614-10618.
15. Hayashi J, Ohta S, Kagawa Y, Takai D, Miyabayashi S, Tada K, Fukushima H, Inui K, Okada S, Goto Y. 1994. Functional and morphological abnormalities of mitochondria in human cells containing mitochondrial DNA with pathogenic point mutations in tRNA genes. J Biol Chem 269:19060-19066.
16. Hoffmann S, Spitkovsky D, Radicella JP, Epe B, Wiesner EJ. 2004. Reactive oxygen species derived from the mitochondrial respiratory chain are not responsible for the basal levels of oxidative base modifications observed in nuclear DNA of mammalian cells. Free Radic Biol Med 36:765-773.
17. Holmuhamedov E, Lewis L, Bienengraeber M, Holmuhamedova M, Jahangir A, Terzic A. 2002. Suppression of human tumor cell proliferation through mitochondrial targeting. FASEB J 16:1010-1016.
18. Jauslin ML, Meier T, Smith RA, Murphy MP. 2003. Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. FASEB J 17:1972-1974.
19. Kavurma MM, Khachigian LM. 2003. Sp1 inhibits proliferation and induces apoptosis in vascular smooth muscle cells by repressing p21WAF1/Cip1 transcription and cyclin D1-Cdk4-p21WAF1/Cip1 complex formation. J Biol Chem 278:32537-32543.
20. Kelso GF, Porteous CM, Coulter CV, Hughes G, Porteous WK, Ledgerwood EC, Smith RA, Murphy MP. 2001. Selective targeting of a redox-active ubiquinone to mitochondria within cells: Antioxidant and antiapoptotic properties. J Biol Chem 276:4588-4596.
21. Kietzmann T, Fandrey J, Acker H. 2000. Oxygen radicals as messengers in oxygen-dependent gene expression. News Physiol Sci 15:202-208.
22. King MP, Attardi G. 1989. Human cells lacking mtDNA: Repopulation with exogenous mitochondria by complementation. Science 246:500-503.
23. Knopp S, Bjorge T, Nesland JM, Trope C, Scheistroen M, Holm R. 2004. p16INK4a and p21Waf1/Cip1 expression correlates with clinical outcome in vulvar carcinomas. Gynecol Oncol 95:37-45.
24. Ko JC, Wang YT, Yang HL. 2004. Dual and opposing roles of ERK in regulating G(1) and S-G(2)/M delays in A549 cells caused by hyperoxia. Exp Cell Res 297:472-483.
25. LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E. 1997. New functional activities for the p21 family of CDK inhibitors. Genes Dev 11:847-862.
26. Laurent A, Nicco C, Chereau C, Goulvestre C, Alexandre J, Alves A, Levy E, Goldwasser F, Panis Y, Soubrane O, Weill B, Batteux F. 2005. Controlling tumor growth by modulating endogenous production of reactive oxygen species. Cancer Res 65:948-956.
27. Lee SR, Kwon KS, Kim SR, Rhee SG. 1998. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem 273:15366-15372.
28. Leslie NR, Bennett D, Lindsay YE, Stewart H, Gray A, Downes CP. 2003. Redox regulation of PI 3-kinase signalling via inactivation of PTEN. EMBO J 22:5501-5510.
29. Li Y, Dowbenko D, Lasky LA. 2002. AKT/PKB phosphorylation of p21Cip/WAF1 enhances protein stability of p21Cip/WAF1 and promotes cell survival. J Biol Chem 277:11352-11361.
30. Liedtke AJ, Nellis SH, Neely JR, Hughes HC. 1976. Effects of treatment with pyruvate and tromethamine in experimental myocardial ischemia. Circ Res 39:378-387.
31. Lill R, Diekert K, Kaut A, Lange H, Pelzer W, Prohl C, Kispal G. 1999. The essential role of mitochondria in the biogenesis of cellular iron-sulfur proteins. Biol Chem 380:1157-1166.
32. Maniura-Weber K, Goffart S, Garstka HL, Montoya J, Wiesner RJ. 2004. Transient overexpression of mitochondrial transcription factor A (TFAM) is sufficient to stimulate mitochondrial DNA transcription, but not sufficient to increase mtDNA copy number in cultured cells. Nucleic Acids Res 32:6015-6027.
33. Medema RH, Kops GJ, Bos JL, Burgering BM. 2000. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404:782-787.
34. Montagne J, Stewart MJ, Stocker H, Hafen E, Kozma SC, Thomas G. 1999. Drosophila S6 kinase: A regulator of cell size. Science 285:2126-2129.
35. Morisaki T, Katano M. 2003. Mitochondria-targeting therapeutic strategies for overcoming chemoresistance and progression of cancer. Curr Med Chem 10:2517-2521.
36. Naderi S, Gutzkow KB, Lahne HU, Lefdal S, Ryves WJ, Harwood AJ, Blomhoff HK. 2004. cAMP-induced degradation of cyclin D3 through association with GSK-3beta. J Cell Sci 117:3769-3783.
37. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. 1991. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 139:271-279.
38. Noseda M, Chang L, McLean G, Grim JE, Clurman BE, Smith LL, Karsan A. 2004. Notch activation induces endothelial cell cycle arrest and participates in contact inhibition: Role of p21Cip1 repression. Mol Cell Biol 24:8813-8822.
39. Page K, Li J, Hodge JA, Liu PT, Vanden Hoek TL, Becker LB, Pestell RG, Rosner MR, Hershenson MB. 1999. Characterization of a Rac1 signaling pathway to cyclin D(1) expression in airway smooth muscle cells. J Biol Chem 274:22065-22071.
40. Park KS, Ahn Y, Kim JA, Yun MS, Seong BL, Choi KY. 2002. Extracellular zinc stimulates ERK-dependent activation of p21(Cip/WAF1) and inhibits proliferation of colorectal cancer cells. Br J Pharmacol 137:597-607.
41. Rochard P, Rodier A, Casas F, Cassar-Malek I, Marchal-Victorion S, Daury L, Wrutniak C, Cabello G. 2000. Mitochondrial activity is involved in the regulation of myoblast differentiation through myogenin expression and activity of myogenic factors. J Biol Chem 275:2733-2744.
42. Rose SL, Goodheart MJ, DeYoung BR, Smith BJ, Buller RE. 2003. p21 expression predicts outcome in p53-null ovarian carcinoma. Clin Cancer Res 9:1028-1032.
43. Rossig L, Badorff C, Holzmann Y, Zeiher AM, Dimmeler S. 2002. Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation. J Biol Chem 277:9684-9689.
44. Roy S, Khanna S, Bickerstaff AA, Subramanian SV, Atalay M, Bierl M, Pendyala S, Levy D, Sharma N, Venojarvi M, Strauch A, Orosz CG, Sen CK. 2003a. Oxygen sensing by primary cardiac fibroblasts: A key role of p21 (Waf1/Cip1/Sdi1). Circ Res 92:264-271.
45. Roy S, Khanna S, Wallace WA, Lappalainen J, Rink C, Cardounel AJ, Zweier JL, Sen CK. 2003b. Characterization of perceived hyperoxia in isolated primary cardiac fibroblasts and in the reoxygenated heart. J Biol Chem 278:47129-47135.
46. Russo T, Zambrano N, Esposito F, Ammendola R, Cimino F, Fiscella M, Jackman J, O'Connor PM, Anderson CW, Appella E. 1995. A p53-independent pathway for activation of WAF1/CIP1 expression following oxidative stress. J Biol Chem 270:29386-29391.
47. Sanjuan-Pla A, Cervera AM, Apostolova N, Garcia-Bou R, Victor VM, Murphy MP, McCreath KJ. 2005. A targeted antioxidant reveals the importance of mitochondrial reactive oxygen species in the hypoxic signaling of HIF-1alpha. FEBS Lett 579:2669-2674.
48. Schulze A, Lehmann K, Jefferies HB, McMahon M, Downward J. 2001. Analysis of the transcriptional program induced by Raf in epithelial cells. Genes Dev 15:981-994.
49. Scott MT, Ingram A, Ball KL. 2002. PDK1-dependent activation of atypical PKC leads to degradation of the p21 tumour modifier protein. EMBO J 21:6771-6780.
50. Seidel-Rogol BL, Shadel GS. 2002. Modulation of mitochondrial transcription in response to mtDNA depletion and repletion in HeLa cells. Nucleic Acids Res 30:1929-1934.
51. Seminario MC, Precht P, Bunnell SC, Warren SE, Morris CM, Taub D, Wange RL. 2004. PTEN permits acute increases in D3-phosphoinositide levels following TCR stimulation but inhibits distal signaling events by reducing the basal activity of Akt. Eur J Immunol 34:3165-3175.
52. Sherr CJ, Roberts JM. 1999. CDK inhibitors: Positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512.
53. Spitkovsky D, Sasse P, Kolossov E, Bottinger C, Fleischmann BK, Hescheler J, Wiesner RJ. 2004. Activity of complex III of the mitochondrial electron transport chain is essential for early heart muscle cell differentiation. FASEB J 18:1300-1302.
54. Taylor WR, Stark GR. 2001. Regulation of the G2/M transition by p53. Oncogene 20:1803-1815.
55. Wang J, Silva JP, Gustafsson CM, Rustin P, Larsson NG. 2001. Increased in vivo apoptosis in cells lacking mitochondrial DNA gene expression. Proc Natl Acad Sci USA 98:4038-4043.
56. Weber K, Ridderskamp D, Alfert M, Hoyer S, Wiesner RJ. 2002. Cultivation in glucose-deprived medium stimulates mitochondrial biogenesis and oxidative metabolism in HepG2 hepatoma cells. Biol Chem 383:283-290.
57. Wolin MS, Ahmad M, Gupte SA. 2005. Oxidant and redox signaling in vascular oxygen sensing mechanisms: Basic concepts, current controversies, and potential importance of cytosolic NADPH. Am J Physiol Lung Cell Mol Physiol 289:L159-L173.
58. Xu Z, Stokoe D, Kane LP, Weiss A. 2002. The inducible expression of the tumor suppressor gene PTEN promotes apoptosis and decreases cell size by inhibiting the PI3K/Akt pathway in Jurkat T cells. Cell Growth Differ 13:285-296.
59. Zerfass K, Levy LM, Cremonesi C, Ciccolini F, Jansen Durr P, Crawford L, Ralston R, Tommasino M. 1995. Cell cycle-dependent disruption of E2F-P107 complexes by human papillomavirus type-16 E7. J Gen Virol 76:1815-1820.
60. Zimmermann S, Moelling K. 1999. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286:1741-1744.